Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT

Rituximab (RTX) is an anti-CD20 monoclonal antibody that targets B cells—from the immature pre-B-cell stage in the bone marrow to mature circulating B cells—while preserving stem cells and plasma cells. It is used to treat autoimmune diseases, hematological malignancies, or complications after hemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Luterbacher, Fanny, Bernard, Fanette, Baleydier, Frédéric, Ranza, Emmanuelle, Jandus, Peter, Blanchard-Rohner, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727997/
https://www.ncbi.nlm.nih.gov/pubmed/35003091
http://dx.doi.org/10.3389/fimmu.2021.773853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727997/
https://www.ncbi.nlm.nih.gov/pubmed/35003091
http://dx.doi.org/10.3389/fimmu.2021.773853

Ejemplares similares